Cost-consequence analysis of secukinumab vs adalimumab in moderate-to-severe hidradenitis suppurativa
{{output}}
Background and objective: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease. Treatment for moderate-to-severe HS includes biologic therapies (adalimumab and secukinumab), resulting in increased disease manageme... ...
